- Home
- SHOO vs VCYT Comparison
SHOO vs VCYT Comparison
Compare SHOO & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHOO | VCYT |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 1993 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SHOO | VCYT |
|---|---|---|
| Price | $43.03 | $42.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $41.00 | ★ $45.38 |
| AVG Volume (30 Days) | ★ 960.3K | 769.3K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | 0.38 |
| Revenue | ★ $2,362,727,000.00 | $495,141,000.00 |
| Revenue This Year | $13.10 | $16.16 |
| Revenue Next Year | $11.74 | $10.92 |
| P/E Ratio | ★ $55.13 | $111.69 |
| Revenue Growth | 6.41 | ★ 16.41 |
| 52 Week Low | $19.05 | $22.61 |
| 52 Week High | $44.99 | $50.71 |
Technical Indicators
Market Signals| Indicator | SHOO | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 46.21 |
| Support Level | $42.45 | $41.90 |
| Resistance Level | $43.90 | $43.86 |
| Average True Range (ATR) | 1.03 | 1.33 |
| MACD | -0.35 | -0.38 |
| Stochastic Oscillator | 22.27 | 19.51 |
Price Performance
Historical ComparisonAbout SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.